SCHEMBL12137964

SCHEMBL12137964

Cc1nc(N)nc(-c2ccc3nccnc3c2)c1-c1ccc(N)nc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TGFBR1 P36897 7/20 0.41
▸ MAPK14 Q16539 3/20 0.41
▸ PIK3CA P42336 2/20 0.36
▸ MTOR P42345 2/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ PIK3CD O00329 1/20 0.36
▸ ABL1 P00519 1/20 0.36
▸ EGFR P00533 1/20 0.36
▸ HCK P08631 1/20 0.36
▸ SRC P12931 1/20 0.36
▸ KDR P35968 1/20 0.36
▸ PIK3CB P42338 1/20 0.36
▸ PIK3CG P48736 1/20 0.36
▸ EPHB4 P54760 1/20 0.36
▸ PRKDC P78527 1/20 0.36
▸ ADORA2A P29274 1/20 0.36
▸ KMT2A Q03164 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ MAT2A P31153 1/20 0.35
▸ HDAC1 Q13547 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12137558 0.86 ADORA2A (0.51) TGFBR1PIK3CAMTORPIK3CDABL1
SCHEMBL12137567 0.86 ALDH1A1 (0.41) MAPK14PIK3CAMTORADORA2AKMT2A
SCHEMBL12137958 0.82 KDM4E (0.42) MAPK14PIK3CAMTORCYP3A4PIK3CD
SCHEMBL12137723 0.80 BACE1 (0.36) MAPK14PIK3CAMTORCYP3A4PIK3CD
SCHEMBL12137720 0.80 PIK3CA (0.45) PIK3CAMTORCYP3A4PIK3CGADORA2A
SCHEMBL12137948 0.80 ADORA2A (0.48) MTORABL1ADORA2AKMT2AMAPT
SCHEMBL12138120 0.79 BACE1 (0.38) MAPK14PIK3CAMTORPIK3CDABL1
SCHEMBL12137956 0.79 PIK3CA (0.44) PIK3CAMTORPIK3CDSRCPIK3CB
SCHEMBL12136125 0.79 MTOR (0.54) PIK3CAMTOR
SCHEMBL12137559 0.79 ADORA1 (0.43) PIK3CAMTORPIK3CDABL1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110281838-A1 5-ALKYNYL-PYRIMIDINES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-11-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110281838-A1 5-ALKYNYL-PYRIMIDINES MKI67, CCNA1, CCNT1 TGFBR1 1074/4885MAPK14 2940/4885PIK3CA 1567/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback